Apogossypolone

Synonyms: ApoG2
Apogossypolone (ApoG2) 是一种具有口服活性的 Bcl-2 family proteins 抑制剂,对 Bcl-2、Mcl-1 和 Bcl-XL 的 Ki 值分别为 35、25 和 660 nM,具有抗肿瘤活性,可诱导细胞凋亡 (apoptosis) 和自噬 (autophagy),并具有抗真菌活性。
产品编号: MS-P39912 纯度: 98.58% CAS No.: 886578-07-0 分子式: C28H26O8 分子量: 490.50
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
1mg
询价
3-5 天
5mg
询价
询价
10mg
询价
询价
50mg
询价
询价

产品描述

Apogossypolone (ApoG2) 是一种具有口服活性的 Bcl-2 family proteins 抑制剂,对 Bcl-2、Mcl-1 和 Bcl-XL 的 Ki 值分别为 35、25 和 660 nM,具有抗肿瘤活性,可诱导细胞凋亡 (apoptosis) 和自噬 (autophagy),并具有抗真菌活性。

生物实验数据

生物活性 Apogossypolone (ApoG2) is an orally active inhibitor of Bcl-2 family proteins with Ki values of 35, 25, and 660 nM for Bcl-2, Mcl-1, and Bcl-XL, respectively, and exhibits antitumor activity by inducing apoptosis and autophagy, as well as antifungal activity.
IC50 & Target Bcl-2:35 nM (Ki), MCL1:25 nM (Ki), Bcl-xL:660 nM (Ki)
体外研究
(In Vitro)

Apogossypolone (ApoG2) shows improved stability under stressed conditions.
Apogossypolone (0-1 μM, 72 or 96 h) inhibits WSU-DLCL2 cells growth in a dose-dependent manner.
Apogossypolone (0-5 μM, 24 or 48 h) interferes with the formation of heterodimers between anti-apoptotic and pro-apoptotic Bcl-2 family members, and leads to cleavage of caspase-3, caspase-9 and PARP.
Apogossypolone (0-8 μM, 0-72 h) induces apoptotic WSU-DLCL2 cell death in a time- and dose-dependent manner.
Apogossypolone (0-10 μM, 0-24 h) induces autophagy and promotes ROS generation in HCC cells.

Cell Proliferation Assay

Cell Line: WSU-DLCL2
Concentration: 250, 350, 500 and 1000 nM
Incubation Time: 96 h for cell counting, 72 h for MTT
Result: Inhibited growth in a dose-dependent manner. The 50% growth inhibition concentration (IC50) was approximately 350 nM.

Western Blot Analysis

Cell Line: WSU-DLCL2
Concentration: 0.35, 0.5, 1 and 5 µM
Incubation Time: 24 or 48 h
Result: Blocked the formation of heterodimers between Bcl-XL and Bim in a concentration-dependent manner. Resulted in the activation of cleavages of caspase-3, caspase-9 and PARP.

Apoptosis Analysis

Cell Line: WSU-DLCL2
Concentration: 0, 1, 2, 4 and 8 µM
Incubation Time: 24, 48 and 72 h
Result: Induced cell apoptosis in a time- and dose-dependent manner.

Cell Autophagy Assay

Cell Line: HepG2 and Hep3B
Concentration: 1.25, 2.5, 5 and 10 µM
Incubation Time: 6, 12, 18 and 24 h
Result: Induced LC3 (Light chain 3)-II conversion in a dose- and time-dependent manner.
体内研究
(In Vivo)

Apogossypolone (ApoG2) (120 mg/kg; i.v. or p.o.; once a day for 5 days) effectively inhibits growth of diffuse large cell lymphoma cells without toxicity.

Animal Model: Four-week-old female ICR-SCID mice, each mouse received 107 WSU-DLCL2 cells (in serum-free RPMI 1640) subcutaneously (sc) in each flank area
Dosage: 120 mg/kg
Administration: Intravenous or administration per day for five days
Result: Inhibited the growth of WSU-DLCL2 and significantly decreased the tumor weight.
Animal Model: Non-tumor-bearing SCID mice
Dosage: 160 mg/kg
Administration: Intravenous or administration per day for five days
Result: Was well tolerated in mice up to 800 mg/kg. Displayed no gross signs of toxicity.
性状 固体
颜色 Orange to reddish brown

化学信息

分子量 490.50
分子式 C28H26O8
CAS No. 886578-07-0
别名 ApoG2

储存&溶解度

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础